相关实验视频

Updated: Jun 30, 2025

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

使用pemetrexed治疗非小细胞肺癌患者的疾病控制:研究最佳治疗策略

Yutaka Takahara¹, Ryudai Abe¹, Nagae Sumito¹

¹Department of Respiratory Medicine, Kanazawa Medical University, Kahoku-gun, Japan.

Thoracic cancer

|March 14, 2024

概括

维持佩姆雷克塞德 (PEM) 剂量和使用具有TTF-1阳性的贝瓦齐祖马布 (Bev) 改善了非小细胞肺癌 (NSCLC) 疾病控制. 这一策略提高了接受PEM治疗的NSCLC患者的生存率.

科学领域:

在瘤学瘤学.
医学瘤学医学瘤学
临床研究临床研究

背景情况:

佩美德 (PEM) 是治疗非小细胞肺癌 (NSCLC) 的关键化疗.
有限的研究存在于PEM治疗期间的疾病控制因素.
这项研究确定了患者的特征和影响NSCLC对PEM反应的因素.

研究的目的:

确定NSCLC患者的临床特征,这些患者对PEM有良好的反应.
预测影响PEM治疗期间疾病控制的因素.
为接受PEM的NSCLC患者提出最佳的治疗策略.

主要方法:

对73名用PEM治疗的NSCLC患者的回顾性分析.
实现疾病控制的患者与未实现疾病控制的患者之间的比较.
多变量分析以确定疾病进展的独立风险因素.

主要成果:

73名患者中有56名 (76.7%) 通过PEM实现了疾病控制.
良好的表现状态和两个周期后不间断的PEM剂量与更好的结果有关.
贝瓦西祖马布 (Bev) 的不合规性,PEM剂量降低和TTF-1阴性独立预测疾病进展.

结论:

在第二个周期后维持PEM剂量对于NSCLC的疾病控制至关重要.
同时使用贝瓦西祖马布 (Bev) 和TTF-1阳性与增强的疾病控制有关.
这些因素共同提高了接受PEM治疗的NSCLC患者的生存率.

关键词:

在TTF-1中,这是bevacizumab的治疗方法.化学疗法化疗化疗非小细胞肺癌的肺癌.在Pemetrexed中使用Pemetrexed.

更多相关视频

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Published on: September 25, 2018

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...